design: randomized, double-blind, placebo-controlled 3-month trial setting: clinical research center patients: 15 postmenopausal women interventions: ct scans at l4/l5, dual energy x-ray absorptiometry (dxa), hyperglycemic clamps main outcome measures: total fat, total abdominal fat, visceral fat, subcutaneous abdominal fat, and insulin secretion.